Non-syndromic urogenital tract malformation of male and female

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:182124
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Non-syndromic urogenital tract malformation of male and female refers to a broad group of congenital structural abnormalities affecting the urinary and genital systems that occur in isolation, meaning they are not part of a recognized genetic syndrome or associated with other systemic anomalies. These malformations can affect the kidneys, ureters, bladder, urethra, and reproductive organs in both males and females. In males, common presentations may include hypospadias, cryptorchidism, renal agenesis, vesicoureteral reflux, or ureteral duplication. In females, malformations may include uterine anomalies, renal agenesis, duplex collecting systems, or other structural abnormalities of the reproductive and urinary tracts. Clinical features vary widely depending on the specific malformation present. Some individuals may be asymptomatic and diagnosed incidentally, while others may present with recurrent urinary tract infections, urinary obstruction, renal impairment, or fertility issues. Diagnosis is typically made through prenatal ultrasound, postnatal imaging studies, or clinical examination at birth or during childhood. Treatment depends on the type and severity of the malformation and may include surgical correction, medical management of associated complications such as infections or reflux, and long-term monitoring of renal function. Many isolated urogenital malformations can be successfully managed with timely surgical intervention. The etiology of non-syndromic urogenital malformations is thought to be multifactorial, involving a combination of genetic susceptibility and environmental factors, though specific causative genes have been identified for some subtypes.

Inheritance

Multifactorial

Caused by a mix of several genes and environmental factors

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Non-syndromic urogenital tract malformation of male and female.

View clinical trials →

No actively recruiting trials found for Non-syndromic urogenital tract malformation of male and female at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Non-syndromic urogenital tract malformation of male and female community →

No specialists are currently listed for Non-syndromic urogenital tract malformation of male and female.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Non-syndromic urogenital tract malformation of male and female.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Non-syndromic urogenital tract malformation of male and femaleForum →

No community posts yet. Be the first to share your experience with Non-syndromic urogenital tract malformation of male and female.

Start the conversation →

Latest news about Non-syndromic urogenital tract malformation of male and female

No recent news articles for Non-syndromic urogenital tract malformation of male and female.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Non-syndromic urogenital tract malformation of male and female

What is Non-syndromic urogenital tract malformation of male and female?

Non-syndromic urogenital tract malformation of male and female refers to a broad group of congenital structural abnormalities affecting the urinary and genital systems that occur in isolation, meaning they are not part of a recognized genetic syndrome or associated with other systemic anomalies. These malformations can affect the kidneys, ureters, bladder, urethra, and reproductive organs in both males and females. In males, common presentations may include hypospadias, cryptorchidism, renal agenesis, vesicoureteral reflux, or ureteral duplication. In females, malformations may include uterine

How is Non-syndromic urogenital tract malformation of male and female inherited?

Non-syndromic urogenital tract malformation of male and female follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Non-syndromic urogenital tract malformation of male and female typically begin?

Typical onset of Non-syndromic urogenital tract malformation of male and female is neonatal. Age of onset can vary across affected individuals.